Vemurafenib
Abstract
Reactions 1680, p332 - 2 Dec 2017 Acute polyneuropathy: case report A 60-year-old man developed acute polyneuropathy during treatment with vemurafenib [route and dosage not stated]. The man, who was diagnosed with BRAF V600E-mutated metastatic melanoma, was started on vemurafenib. He was also taking cobimetinib concomitantly. Four weeks after the start of vemurafenib, he experienced tingling of the feet, which progressed to the fingertips in days. Subsequently, he experienced weakness of...